Neuraltus Pharmaceuticals, Inc.;The Regents of the University of California
发明人:
MCGRATH, Michael S.,AZHIR, Arasteh Ari
申请号：
AU2016202631
公开号：
AU2016202631A1
申请日:
2016.04.26
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
#$%^&*AU2016202631A120160519.pdf#####ABSTRACT The present invention provides a method of treating a macrophage related disease comprising administering to a subject in need thereof an effective amount of an oxidative agent or an immunosuppressive agent. The present invention also provides a method of modulating macrophage accumulation or activation comprising administering to a subject in need thereof an effective amount of an oxidative agent or an immunosuppressive agent. The oxidative agent can be chlorite or a chlorite containing compound.
